Terazosin
- Product NDC
- 67296-1264
- 11-digit product format
- 672961264
- Labeler code
- 67296
- Product ID
- 67296-1264_d6103513-b2b5-1fd0-e053-2995a90a41ef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2004-12-20
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1264-3 | Terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1264 | TERAZOSIN CAPSULE [REDPHARM DRUG, INC.] | 3 | Legacy NDC, 1 package rows | 20220121_4fa716c7-d6ef-2217-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1264-3 | 67296126403 | 30 CAPSULE in 1 BOTTLE (67296-1264-3) | 30 capsule | 2004-12-20 | 0000-00-00 | No | No | Current |